- The aim of the report “Barriers to access to innovative treatment in selected cancer diseases” was to analyze the existing barriers in the Polish health care system related to access to modern oncological treatment, using the example of two cancers (selected by Presidium of All.Can Poland) – lung and kidney.
- The publication was developed by IQVIA Commercial Consulting on behalf of All.Can Polska with the support of MSD Polska in Q1&Q2 2024.
- The report includes comments from:
- Maciej Krzakowski, Head of the Lung and Chest Cancer Clinic at NIO-PIB, National Consultant in the field of clinical oncology, President of PTOK, Member of the Presidium of All.Can Polska
- Jacek Jassem, Head of the Department and Clinic of Oncology and Radiotherapy, specialist in the field of oncological radiotherapy and clinical oncology; President of the board of the Polish Cancer Fighting League, chairman of the Central and East European Oncology Group; Member of All.Can Polska
- Szymon Chrostowski, Head of Presidium of All.Can Poland
- The authors of the report recommend:
- Increasing the total budget for reimbursement and optimizing the use of funds already available in the system;
- Improving the transparency and predictability of issuing reimbursement decisions;
- Reorganizing the administrative process related to launching and expanding the scope of drug programs, including in the scope of contracting services;
- Preparing and promoting guidelines for primary care physicians in the scope of conducting oncological interviews;
- Full use of the postponement of the reform concerning the National Oncology Network to properly prepare the system for this significant change, as indicated in the report, a properly implemented KSO is the key to addressing some of the barriers in access and quality of oncological treatment, including in the scope of the dispersion of diagnostic and therapeutic centers;
- Updating and adjusting to the actual conditions of service valuations, including in the scope of services provided under drug programs (treatment administration, diagnostics and monitoring) or genetic diagnostics (molecular and pathomorphological);
- Comprehensive reform of the financing system: The current conditions of financing treatment (especially hospital treatment) within the public system have led to a very poor economic situation in most medical entities. The issue of debt of medical facilities requires a comprehensive reform of the system, going beyond the field of oncology, but it should be emphasized that it significantly affects the barriers in access to innovative treatment in Poland.
- The launch of the report took place on 8th November during press conference.
The speakers:
- dr hab. n. med. Maciej Krzakowski,
- dr hab. n. med. Adam Płużański,
- dr hab. n. med. Jakub Kucharz,
- Szymon Chrostowski,
- Andrzej Mazurek, Associate Director, Public Health & PPG IQVIA
- Jacek Wieczorek, Manager Consulting IQVIA
There were over 40 participants.
As a result there were 22 publications with the reach 5 971 184 users and AVE 144 060 PLN
The reports and its recommendations are presented at All.Can Poland Social media: X, Facebook and LinkedIn
PLANS
- The report will be delivered to selected decision makers from Ministry of Health, National Health Fund, AOTMiT and Parliamentarians – Nov/Dec 24
- The report will be presented at the meeting of AmCham Poland – Dec 24
- The report will be presented at the yearly meeting of All.Can Poland members – Jan 25
Re report is available at webpage of All.Can Polska: